PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

Application, page-17

  1. 1,226 Posts.
    lightbulb Created with Sketch. 177
    Hello all. Interesting article by Blokey above. Always good to see others discussion regarding Paradigm and investment thoughts.

    In digging around for Paradigm related information, I come across some other trials for treatments of OA. I thought that I would share a few of these with you, to keep you guessing how or if anothernon opioid medical treatment will compare to Zilusol:

    American Journal of Sports Medicine Publishes Results of an FDA-Approved Clinical Trial Treating Osteoarthritis Knee Pain



    Clinical Efficacy of Intra-articular Mesenchymal Stromal Cells for the Treatment of Knee Osteoarthritis: A Double-Blinded Prospective Randomized Controlled Clinical Trial - Jaime R. Garza, Richard E. Campbell, Fotios P. Tjoumakaris, Kevin B. Freedman



 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.